Search Results

You searched for : LatestPharmaNewsNov2  

Apollo Hospitals, Bangalore has introduced Robotic Assisted Joint Replacement Program

The Robotic system has an advanced computed program that relays precise information about the knee with 3D mapping....
Nov 27

Roche announces FDA approval of Xofluza

Xofluza for the prevention of influenza following contact with an infected person...
Nov 27

Glenmark Pharmaceuticals secures its position in the prestigious Dow Jones Sustainability Emerging Markets Index

DJSI is one of the world’s most respected and widely accepted sustainability benchmarks globally with only the top-ranked companies in terms of Corporate ...
Nov 26

Laurus Labs forays into biotech, acquires majority stake in Richcore Lifesciences

Laurus Labs to acquire 72.55 per cent of Richcore’s shares for a value of Rs 246.7 crores...
Nov 26

RhoVac's Prostate Cancer Drug Candidate, RV001, is granted Fast Track Designation by the FDA

Latest FDA News Nov 26, 2020...
Nov 26

Bristol Myers Squibb Receives European Commission Approval for Opdivo

Bristol Myers Squibb announced the approval of Opdivo for the treatment of adults with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma ...
Nov 25

Piramal Sarvajal and Center for Water and Sanitation Launch Composite Water Vulnerability Index Tool

Piramal Sarvajal, the safe drinking water initiative of Piramal Foundation launched a tool named Composite Water Vulnerability Index at its recent Webinar on ‘Sustainable Water ...
Nov 25

Alembic Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Testosterone Gel

Testosterone Gel, is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone....
Nov 25

Lokelma label update approved in China for patients with hyperkalaemia on chronic haemodialysis

The NMPA has approved a dosing label update in China for AstraZeneca’s Lokelma to include patients with hyperkalaemia on chronic haemodialysis....
Nov 25

Lupin launches Tacrolimus Capsules USP

Tacrolimus Capsules are the generic equivalent of Prograf Capsules of Astellas Pharma US, Inc. and are indicated for the prophylaxis of organ rejection....
Nov 25

PFIZER DOSES FIRST PARTICIPANT IN PHASE 3 STUDY EVALUATING ANTI-TFPI INVESTIGATIONAL THERAPY

An anti-tissue factor pathway inhibitor being evaluated for the treatment of people with severe hemophilia A or B, with or without inhibitors....
Nov 23

Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure

The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with ...
Nov 23

Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19

Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease...
Nov 23

European Commission approves MenQuadfi, the latest innovation in meningococcal vaccination

The EC has approved MenQuadfi for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y....
Nov 23

GSK starts phase 3 study of RSV maternal candidate vaccine

Currently no vaccine is available for respiratory syncytial virus...
Nov 23

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in ...
Nov 23

Merck Submits Applications for Licensure of V114, the Company’s Investigational 15-valent Pneumococcal Conjugate Vaccine

...
Nov 23

Strides receives USFDA approval for Prednisone Tablets

...
Nov 23

GSK and MMV present positive data on treatment for Plasmodium vivax malaria in children

GSK and MMV today presented positive data from the TEACH study of tafenoquine, an 8-aminoquinoline, for the prevention of relapse of Plasmodium vivax malaria ...
Nov 20

Sun Pharma announces 5-Year sustained efficacy and safety results for ILUMYA (tildrakizumab-asmn)

...
Nov 02

20 Matching result(s) found!

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026